Wissenschaftliche Publikationen
Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, Kindgen-Milles D, Neumayer HH.
A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Critical Care Medicine, Crit Care Med. 2009 Jun;37(6):2018-24
Bagshaw SM, Uchino S, Cruz D, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transplant. 2009 Apr 6. [Epub ahead of print]
Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care. 2009 Mar;24(1):129-40. Epub 2008 Apr 18.
Kleeberg L, Morgera S, Jakob C, Hocher B, Schneider M, Rötzer S, Müller C, Kaiser M, Fleissner C, Heider U, Neumayer HH, Sezer O.
Novel Renal Replacement Strategies for the Elimination of Serum Free Light Chains in Patients with Kappa Light Chain Nephropathy. Eur J Med Res. 2009 Feb 18;14(2):47-54.
Morgera S, Schneider M, Neumayer HH. Long-term outcomes after acute kidney injury. Crit Care Med. 2008 Apr;36(4 Suppl):S193-7
Kindgen-Milles D, Kram R, Kleinekofort W, Morgera S. Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation. ASAIO J. 2008 Jul-Aug;54(4):442-4.
Kindgen-Milles D, Amman J, Kleinekofort W, Morgera S. Treatment of metabolic alkalosis during continuous renal replacement therapy with regional citrate anticoagulation. Int J Artif Organs. 2008 Apr;31(4):363-6.
Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Storr M, Krause B, Boyce N, Svobodova S, Li W, Bagshaw SM, Warrillow S, Langenberg C, Morgera S. The effect of three different miniaturized blood purification devices on plasma cytokine concentration in an ex vivo model of endotoxinemia. Int J Artif Organs. 2008 Aug;31(8):722-9
Schneider M, Liefeldt L, Slowinski T, Peters H, Neumayer HH, Morgera S. Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure. Int J Artif Organs. 2008 Jan;31(1):43-8.
Krämer S, Kron S, Wang-Rosenke Y, Loof T, Khadzhynov D, Morgera S, Kawachi H, Shimizu F, Martini S, Neumayer HH, Peters H. Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis. Am J Physiol Renal Physiol. 2008 Apr;294(4):F801-11. Epub 2008 Jan 23.
Haase M, Haase-Fielitz A, Ratnaike S, Reade MC, Bagshaw SM, Morgera S, Dragun D, Bellomo R. N-Acetylcysteine does not artifactually lower plasma creatinine concentration. Nephrol Dial Transplant. 2008 May;23(5):1581-7
Morath C, Miftari N, Dikow R, Hainer C, Zeier M, Morgera S, Weigand MA, Schwenger V.
Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrol Dial Transplant. 2008 Jan;23(1):421-2.
Fischer T, Filimonow S, Rudolph J, Morgera S, Budde K, Slowinski T, Ebeling V, Taymoorian K, Giessing M, Thomas A. Arrival Time Parametric Imaging: A New Ultrasound Technique for Quantifying Perfusion of Kidney Grafts. Ultraschall Med. 2008 Aug;29(4):418-23.
Schneider M, Thomas K, Liefeldt L, Kindgen-Milles D, Peters H, Neumayer HH, Morgera S. Efficacy and safety of intermittent hemodialysis using citrate as anticoagulant: a prospective study. Clin Nephrol. 2007 Nov;68(5):302-7.
Morgera S, Neumayer HH. Diabetes mellitus und Niere – Vereint bis in den Tod. Deutsche Med. Wochenschrift, 2007
Haase M, Bellomo R, Morgera S, Baldwin I, Boyce N.
High cut-off point membranes in septic acute renal failure: a systematic review. Int J Artif Organs. 2007 Dec;30(12):1031-41.
Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007 May;2(3):431-9.
Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Fealy N, Davenport P, Morgera S, Goehl H, Storr M, Boyce N, Neumayer HH. Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. Am J Kidney Dis. 2007 Aug;50(2):296-304.
Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007 Sep;33(9):1563-70.
Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA. Continuous renal replacement therapy: A worldwide practice survey : The Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Intensive Care Med. 2007 Sep;33(9):1563-70.
Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Fealy N, Morgera S, Goehl H, Storr M, Boyce N, Neumayer HH. Beta2-microglobulin removal and plasma albumin levels with high cut-off hemodialysis. Int J Artif Organs. 2007 May;30(5):385-92
Uchino S, Bellomo R, Kellum JA, Morimatsu H, Morgera S, Schetz MR, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-Van Straaten HM, Ronco C. Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators Writing Committee. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs. 2007 Apr;30(4):281-92
Birnbaum J, Spies CD, Klotz E, Hein OV, Morgera S, Schink T, Ziemer S, Grund MS, Saalmann R, Kox WJ, Lehmann C. Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Ren Fail. 2007;29(3):271-7
Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S, Matalanis G, Buxton B, Doolan L, Bellomo R. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med. 2007 May;35(5):1324-31
Fischer T, Filimonow S, Dieckhofer J, Slowinski T, Muhler M, Lembcke A, Budde K, Neumayer HH, Ebeling V, Giessing M, Thomas A, Morgera S. Improved diagnosis of early kidney allograft dysfunction by ultrasound with echo enhancer--a new method for the diagnosis of renal perfusion. Nephrol Dial Transplant. 2006, 21(10):2921-9
Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med. 2006 Aug;34(8):2099-104.
Langenberg C, Bellomo R, May CN, Egi M, Wan L, Morgera S. Renal Vascular Resistance in Sepsis. Nephron Physiol. 2006 May 10;104(1):p1-p1
Haase M, Morgera S, Bamberg C, Halle H, Martini S, Dragun D, Neumayer HH, Budde K. Successful pregnancies in dialysis patients including those suffering from cystinosis and familial Mediterranean fever. J Nephrol. 2006, 19(5):677-81
Fischer T, Filimonow S, Mutze S, Morgera S, Thomas A. Renal transplant: color duplex ultrasound and contrast-enhanced ultrasound in the evaluation of the early postoperative phase and surgical complications. Rofo. 2006 Dec;178(12):1202-11
Haase M, Morgera S, Budde K. A systematic approach to managing pregnant dialysis patients--the importance of an intensified haemodiafiltration protocol. Nephrol Dial Transplant. 2006 Feb 27;
Fischer T, Ebeling V, Giessing M, Muhler M, Filimonow S, Dieckhofer J, Lembcke A, Rudolph J, Morgera S, Budde K, Hamm B, Thomas A. [A new method for standardized diagnosis following renal transplantation. Ultrasound with contrast enhancement]. Urologe 2006 Jan;45(1):38-45.
Morgera S, Haase M, Ruckert M, Krieg H, Kastrup M, Krausch D, Vargas-Hein O, Zuckermann-Becker H, Peters H, Pohlmeier R, Neumayer HH. Regional Citrate Anticoagulation in Continuous Hemodialysis - Acid-Base and Electrolyte Balance at an Increased Dose of Dialysis. Nephron Clin Pract. 101(4):c211-c219, 2005
Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S. Renal blood flow in sepsis. Crit Care. 9(4):R363-374, 2005
Haase M, Bellomo R, Rocktaeschel J, Ziemer S, Kiesewetter H, Morgera S, Neumayer HH. Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II. Nephrol Dial Transplant. 20(2):444-6, 2005
Morgera S. Management of ARF with high permeability hemofiltration in sepsis: practical aspects. International Journal of Intensive Care. 8:25-31, 2005
Von Heymann C, Vargas Hein O, Kastrup M, Morgera S, Ziemer S, Spies C. HIT Typ II in der operativen Medizin – therapeutische Optionen. Vascular Care. 1:24-53, 2005
Fischer T, Dieckhöfer J, Mühler M, Lembcke A, Morgera S, Budde K, Neumayer HH, Ebeling V, Thomas A, Filimonow S. The use of contrast-enhanced US in renal transplant: first results and potential clinical benefit. Eur Radiol. 2005 Dec;15 Suppl 5:E109-16.
Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Doig GS, van Straaten HO, Ronco C, Kellum JA; for the Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. External validation of severity scoring systems for acute renal failure using a multinational database. Crit Care Med. 33(9):1961-1967, 2005
Haase M, Morgera S, Bamberg C, Halle H, Martini S, Hocher B, Diekmann F, Dragun D, Peters H, Neumayer HH, Budde K. A systematic approach to managing pregnant dialysis patients--the importance of an intensified haemodiafiltration protocol. Nephrol Dial Transplant. Aug 22, 2005
Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 294(7):813-818, 2005
Vargas Hein O, Staegemann M, Wagner D, von Heymann C, Martin M, Morgera S, Spies C. Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients. Ren Fail. 27(4):385-392, 2005
Hein OV, von Heymann C, Morgera S, Konertz W, Ziemer S, Spies C. Protracted bleeding after hirudin anticoagulation for cardiac surgery in a patient with HIT II and chronic renal failure. Int J. Artif Organs. 29(6):507-510, 2005
IF 1.3
Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer HH, Bellomo R. Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report. Crit Care. 9(2):R90-95, 2005
Morgera S, Schlenstedt J, Giessing M, Deger S, Hocher B, Neumayer HH. Glucose-mediated Transforming Growth Factor-beta1 Release in Human Mesothelial Cells is Endothelin Independent. J Cardiovasc Pharmacol. 44:S216-S218, 2004
Morgera S, Scholle C, Melzer C, Slowinski T, Peters H, Baumann G, Neumayer HH. A simple, safe and effective citrate anticoagulation protocol for the Genius dialysis. Nephron Clin Prac. 98(1):c35-40, 2004
Morgera S, Scholle C, Voss G, Vargas-Hein O, Haase M, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH. Metabolic complications during regional Citrate Anticoagulation in Continuous Veno-venous Hemodiafiltration. Single center experience. Nephron Clin Prac. 97(4):c131-136, 2004
Lee WCR, Uchino S, Fealy N, Baldwin I, Panagiotopoulos S, Goehl H, Morgera S, Neumayer HH, Bellomo R. Super high flux hemodialysis at high dialysate flows: An ex vivo assessment. Int J Artif Organs 27:24-28, 2004
Morgera S, Schlenstedt J, Giessing M, Deger S, Hocher B, Neumayer HH. Glucose mediated TGF-ß1 release in human mesothelial cells is endothelin independent. J Cardiovasc Pharm 44: S216-S218, 2004.
Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Müller JM, Baumann G, Kox WJ, Bellomo R, Neumayer HH. Renal replacement therapy with high cut-off hemofilters : Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis. 43(3):444-453, 2004
Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Nacedo E, Gibney N, Tolwani A, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Diuretics and mortality in acute renal failure. Crit Care Med. 32(8):1669-1677, 2004
Giessing M, Reuter S, Schönberger B, Deger S, Tuerk I, Hirte I, Budde K, Fritsche L, Morgera S, Dragun D, Neumayer HH, Loening SA. Quality of life of living kidney donors in Germany – a survey with the validated SF-36 and GBB-24 questionnaires. Transplantation. 78(6):864-72, 2004
Lee WC, Uchino S, Fealy N, Baldwin I, Panagiotopoulos S, Goehl H, Morgera S, Neumayer HH, Bellomo R: Beta2-microglobulin clearance with super high flux hemodialysis: an ex vivo study. Int J Artif Organs 26:723-727, 2003
Morgera S, Schlenstedt J, Hambach P, Giessing M, Deger S, Hocher B, Neumayer HH. Combined ETA/ETB receptor blockade of human peritoneal mesothelial cells inhibits collagen-I RNA synthesis. Kidney Int 64(6):2033-40, 2003Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B: Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23:288-296, 1997
Hollenbeck M, Kutkuhn B, Bosma A, Morgera S, Grabensee B: [The value of noninvasive 24-hour blood pressure measurement in patients with renoparenchymal, renovascular or severe essential hypertension]. Z Kardiol 81 Suppl 2:29-32, 1992
